ERMs are among the most common causative agents of occupational ACD. 2, 3 They are known to be extremely sensitizing to the skin and can sensitize upon first contact. 4 ACD has been reported from various epoxy resin system components, [5] [6] [7] [8] [9] [10] [11] [12] [13] most commonly from exposure to DGEBA and DGEBF. 14, 15 DGEBA is included in the European baseline series for diagnosis of ACD. 16 We are interested in ERS from a healthcare perspective as they are known to be extremely sensitizing to the skin. Contact allergy to epoxy resins is widespread in dermatitis patients with a reported prevalence ranging from 0.9 to 2.3%. [17] [18] [19] [20] Reported prevalences in occupational settings are higher, with between 11.7 and 12.5% of cases of allergic contact dermatitis (ACD) attributable to epoxy chemicals. 21 Studies from workplaces found exceptionally high rates of ACD from ERS in aircraft manufacturing workers (56%) 7 and marble workers (45%) 22 , amongst others. Skin sensitization is also common amongst construction workers (up to 9.7%) and is caused by ERS present in cement and other building materials, 18, 23 but is also frequent in newer settings such as the production of wind turbine rotor blades 15 and relining of old pipes. 13 It can also occur in unexpected settings such as microscopy of histological samples, due to the presence of ERS in the microscopy immersion oil. 24, 25 Epoxy chemicals are also implicated in non-occupational contact allergy. 17, 26 Skin sensitization potential has been investigated experimentally in vivo in mice and guinea pigs for DGEBA, 27, 28 DGEBF 28, 29 and others. 30, 31 DGEBA and DGEBF are classified as strong sensitizers in both species according to regulatory guidelines. 32 It would be highly advantageous to replace these strongly sensitizing ERMs with less hazardous alternatives.
Our research aims to reduce the adverse skin sensitizing effects of ERMs whilst maintaining their excellent ability to form thermosetting polymers. This is a challenging task in which it is vital to keep a certain level of reactivity in order to enable polymerization. We have previously shown that the sensitizing effects of the epoxy resin DGEBF are directly related to the presence of the terminal epoxide groups. 33 In the present study, compounds that incorporate terminal epoxy groups with reduced reactivity have been designed by alteration of the total chemical structure of the ERMs (1-6, Figure 1 ). The polymerization potential of the novel ERMs 1-6 was evaluated using differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA).
The skin sensitizing potency was assessed using the in vivo murine local lymph node assay (LLNA). 34
Experimental Procedures
Caution: This study involves skin sensitizing compounds which must be handled with care.
Instrumentation and Mode of Analysis. 1 H and 13 C NMR spectroscopy was performed on a Jeol Eclipse 400 spectrometer at 400 MHz and 100 MHz, respectively, using CDCl3 (residual CHCl3 δ 7.26 and δ 77.0 as internal standards) or DMSO-d6 (residual (CH3)2SO δ 2.54 and δ 40.45 as internal standards) solutions. Electron-ionization mass spectral analysis (70 eV) was performed on a Hewlett-Packard 5973 mass spectrometer connected to a gas chromatograph (Hewlett-Packard 6890). The GC was equipped with a cool on-column capillary inlet and an HP-5MSi fused silica capillary column (30 m×0.25 mm, 0.25 µm, Agilent Technologies, Palo Alto, CA). Helium was used as carrier gas, and the flow rate was 1.2 mL/min. The temperature program started at 70 °C for 1 min, increased by 10 °C/min for 20 min, and ended at 270 °C for 5 min. For mass spectral analysis, the mass spectrometer was used in the scan mode detecting ions with m/z values from 50 to 1500.
High performance liquid chromatography/mass spectrometry (LC/MS) analyses were performed using electrospray ionization (ESI) on a Hewlett-Packard 1100 HPLC/MS. The system included a vacuum degasser, a binary pump, an autoinjector, a column thermostat, a diode array detector, and a single quadrupole mass spectrometer. The HPLC was equipped with a HyPURITY C18 column (150×3 mm i. d., particle size 3 µm, Thermo Hypersil-Keystone, Thermo Electron Corp., Bellafonte, PA). The mobile phase consisted of 0.005% pentafluoropropanoic acid, 0.1% acetic acid, and 5% acetonitrile in water (solvent A) and 0.005% pentafluoropropanoic acid, 0.1% acetic acid, and 50% water in acetonitrile (solvent B). A linear gradient from 0% to 100% B over 20 min, followed by 10 min of isocratic elution was used. The flow rate was 0.4 mL/min and the column temperature was 40 °C. The electrospray interface was used with the following spray chamber settings: nebulizer pressure, 40 psig; capillary voltage, 3500 V; drying gas temperature, 350 °C; and drying gas flow rate, 10 L/min. Fragmentor voltage was set to 120 V. The mass spectrometer was used in scan mode detecting molecular ions with m/z values ranging from 50 to
2000.
DGEBA and DGEBF were purchased from Sigma-Aldrich; DGEBF was obtained as a mixture of three isomers. Sodium hydride (60% dispersion in mineral oil) was washed twice with hexane and dried with N2 prior to use. Acetone was purchased from Merck (Darmstadt, Germany) and olive oil from Apoteket AB (Goteborg, Sweden). Unless otherwise indicated, reagents were obtained from commercial suppliers and were used without further purification. TLC was performed using silica gel coated aluminum plates. The purity of all test compounds was >98% (GC/MS) before evaluation in biological assays.
Chemical Synthesis

Synthesis of bis[4-(2,3-epoxypropoxy)cyclohexyl]methane (2) (Scheme 1)
4,4'-Methylenedicyclohexanol (2a).
A solution of 4,4'-methylenediphenol (0.05 M solution in isopropanol) was reacted in an H-cube® continuous flow hydrogenation reactor (ThalesNano©) at 100 °C, 100 bar at a flow rate of 1 mL/min and employing 5% Ru/C (30 mm CatCart™) as catalyst. The reaction was monitored by TLC until the starting material was consumed. The solvent was evaporated in vacuo and aqueous NaOH solution (50 mL, 10% w/v) was added. The mixture was stirred for 10 min and extracted twice with ethyl acetate (50 mL). The organic fraction was reduced in vacuo and the white residue was recrystallized from diethyl ether to give compound 2a in 98% yield as a white powder (mixture of isomers). 1 with hexane (20 mL×2), suspended in anhydrous THF (40 mL) and cooled to 0 °C. Compound 2a (4 mmol) was dissolved in anhydrous THF (20 mL) and added to the suspension. The mixture was stirred at 0 °C for 10 min. Allyl bromide (10.4 mmol, 2.6 equiv.) was added and the mixture was stirred at room temperature for 90 min before refluxing overnight. The reaction was continued until TLC indicated disappearance of the starting material. The mixture was cooled to 0 °C and saturated aqueous NH4Cl (70 mL) was added slowly to quench the reaction. The aqueous layer was extracted with ethyl acetate (70 mL×3). The combined organic fractions were washed with brine (150 mL), dried over anhydrous Na2SO4 and reduced in vacuo. The product 2b was isolated by column chromatography (9:1 hexane: ethyl acetate) and was obtained as a colorless oil in 93% yield. 1 was added and the mixture was stirred at 0 °C for 2 h. The mixture was then stirred at room temperature with addition of further mCPBA as necessary until complete on TLC. Aqueous NaOH (10% w/v) (40 mL) was added and extracted with CH2Cl2 (40 mL). The organic phase was washed with brine, dried over anhydrous Na2SO4 and reduced in vacuo. The product 2 was isolated as a mixture of isomers by column chromatography (9:1 hexane: ethyl acetate) as a colorless oil in 76% yield. (1) was prepared from 1b by the same method used to prepare compound 2 from 2b. The product 1 was isolated as a mixture of isomers by column chromatography (8:2 hexane: ethyl acetate) as a colorless oil in 82% yield. 1 
2,2-Bis[4-(2,3-epoxypropoxy)cyclohexyl]propane
Synthesis of bis[4-(3,4-epoxybutoxy)phenyl]methane (4) (Scheme 2)
Bis[4-(but-3-en-1-yloxy)phenyl]methane (4a). 4,4'-Methylenediphenol (5 mmol) was
dissolved in DMF (20 mL) and K2CO3 (20 mmol, 4 equiv.) was added. 4-Bromo-1-butene (15 mmol, 3 equiv.) was added. The mixture was warmed to 40 o C and stirred overnight. Water was added to quench the reaction. After extraction with EtOAc, the organic phase was washed with 2M HCl, brine and dried over anhydrous Na2SO4. The product 4a was isolated using column chromatography (5:2 hexane: EtOAc) (61%) and used in the next step without further characterization. 1 
Synthesis of 2,2-bis[4-(3,4-epoxybutoxy)phenyl]propane (3) (Scheme 2)
2,2-Bis(but-3-en-1-yloxy)phenyl]propane (3a)
was prepared from 2,2-bis(4hydroxyphenyl)propane by the same method used to prepare compound 4a. The product 3a was isolated using column chromatography (5:2 hexane: EtOAc) (19%). 1 were calculated by linear interpolation. The sensitizing potency was classified to the following:
≤0.2% w/v, extreme; >0.2 to ≤2% w/v, strong; >2% w/v moderate. 32 For registration in REACH, the LLNA is the preferred method for measuring skin sensitization potential in animals. 36, 37 LLNA with non-pooled lymph nodes. Single-cell suspensions of the lymph nodes from individual mice were prepared and the [methyl- 3 
Results and Discussion
To the best of our knowledge, this is the first time that novel DGEBA and DGEBF analogs are described that maintain the excellent technical properties of currently available ERMs while reducing their harmful allergenic effects. By modifying the intrinsic reactivity of ERMs, we have addressed the underlying causes of contact allergy to ERS. We thereby hope to diminish the problem of ACD caused by ERS, especially in occupational settings. We have adopted a global approach incorporating medicinal chemistry and toxicology to design new ERMs.
ERM Design and Synthesis
The design was focused on alternatives to DGEBA and DGEBF as these are the most commonly used ERMs and are described as the main cause of epoxy allergy. 21 Six novel ERMs (three of DGEBA and three of DGEBF) were synthesized and evaluated (ERMs 1-6, Figure 1 ). The new compounds were designed to reduce the reactivity of the terminal epoxide enough to decrease the skin sensitizing potency but without compromising the ability to polymerize. This functional group is necessary for the desirable polymerization properties of DGEBA and DGEBF but we have previously shown that the sensitizing effects of DGEBF are directly related to the presence of the terminal epoxide groups. 33 Hence, the terminal epoxide group was retained but its reactivity decreased by alteration of other molecular features. Each novel ERM had slight structural modifications compared to DGEBA and DBEBF, designed to give delicately balanced structures capable of polymerization without excessive reactivity causing skin sensitization.
ERMs 1-6 were designed based on previous work on the epoxy reactive diluent phenylglycidyl ether (PGE). 31, 38 Structural modifications to PGE that were found to give reduced skin sensitization potency were incorporated into the new ERMs. ERMs 1 and 2 have cyclohexane rings instead of aromatic, compounds 3 and 4 have a 2-carbon aliphatic chain between the ether oxygen and the epoxide ring instead of a 1-carbon chain, and the ether oxygen is removed in compounds 5 and 6 (Figure 1 ).
ERM 2 was synthesized in three steps from bisphenol F (Scheme 1). After hydrogenation of the two aromatic rings at 100 °C and 100 bar (step i), alkylation with allyl bromide in the presence of sodium hydride (step ii) and subsequent epoxidation with 3-chloroperbenzoic acid (mCPBA) (step iii) yielded the final product 2 in 69% overall yield. Hydrogenation was found to proceed faster in isopropanol compared to ethanol. 39 ERMs 3 and 4 were synthesized in two steps from bisphenol A and bisphenol F, respectively (Scheme 2). Alkylation with 4-bromo-1-butene in the presence of base (step i) followed by epoxidation with mCPBA (step ii) gave the desired products 3 and 4 in overall yields of 7% and 32%, respectively. Potassium carbonate was found to be a suitable base, whereas neither triethylamine nor sodium hydride were appropriate. DMF was found to be a superior solvent to both THF and methanol.
It was initially intended to synthesize ERMs with a two-carbon aliphatic linker between the aromatic ring and the terminal epoxide group. 3-Butenyltributylstannane was synthesized from tri-n-butyltin chloride 40 but attempts to couple it with bisphenol F were unsuccessful. Instead, allyltributylstannane was used to give compounds with a one-carbon linker. ERMs 5 and 6 were prepared from bisphenol A and bisphenol F respectively in three steps (Scheme 3). Triflation of the phenolic groups (step i) was followed by microwave-assisted Stille coupling to allyltributylstannane (step ii). 41 Finally, 5 and 6 were obtained by epoxidation with mCPBA (step iii) in overall yields of 29% and 26%, respectively.
Skin Sensitizing Potency Studies
The murine local lymph node assay (LLNA) was used to assess the skin sensitizing potency of the compounds. 42 Figure 2 ), further in vivo testing was carried out only on analogs of DGEBF (ERMs 4 and 6) due to ethical considerations.
All four of the novel ERMs tested had reduced in vivo sensitizing potencies compared to DGEBA and DGEBF (Figure 2 and Supporting Information Table S1 ). The difference in the EC3 values of the two commercial products (DGEBA and DGEBF) and our four ERMs is illustrated in Figure 2 To establish whether there was a statistically significant difference between the sensitizing potencies of the new ERMs and DGEBA, an extension of the LLNA using non-pooled lymph nodes was applied. This modified method was used in our previous work with epoxy resin analogs as well as in other studies by the group. 38, 44 For ethical reasons, we did not want to repeatedly perform LLNA experiments and therefore only ERM 5 was compared with DGEBA.
We chose to use the DGEBA analogue 5, structurally related to the least sensitizing DGEBF analogue 6, for this experiment as the sensitizing potencies of the pairs of DGEBA/F analogues tested in the ordinary LLNA with pooled lymph nodes were similar. Statistical analysis revealed that DGEBA was significantly more potent in inducing lymph node cell proliferation than 5 at the chosen concentration of 0.064 M. (P<0.0001, Figure 3 and Table S2 , Supporting Information), indicating that DGEBA is significantly more sensitizing than 5.
Examining the results of all LLNA in vivo experiments indicates that the newer ERMs are less skin sensitizing than DGEBA and DGEBF. The new ERMs are classified as moderate skin sensitizers in comparison to DGEBA and DGEBF, which are strong skin sensitizers. 32 To our knowledge, these are the first reported ERMs that are only moderately sensitizing. This is also the first time that a combined medicinal chemistry/toxicology approach has been used to design ERMs specifically aimed at reducing contact allergy. A reduction in the incidence of ACD due to occupational and non-occupational contact with ERS could be obtained by use of alternative, less sensitizing ERMs such as these alternative compounds.
Polymers from the ERMs
The thermal properties and suitability for polymerisation of the new ERMs were investigated.
Epoxy resins were prepared from the novel ERMs using triethylenetetramine (TETA) as the coreactant (Scheme 4). TETA was chosen because it is commonly used as a curing agent for epoxy resins. 45 The thermal properties of the epoxy resins were assessed using differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) and the results were compared to epoxy resins based on DGEBA and DGEBF, prepared with the same molar ratio of the components and under the same reaction conditions.
The DSC results showed that the polymers prepared from ERMs 2 and 4, DGEBA and DGEBF had almost the same glass transition temperature (Tg), between 42 and 43.6 °C (Table S3 , Supporting Information). A Tg value of 40-45 °C has previously been reported for an epoxy resin based on DGEBA/TETA with the same molar ratio. Thus, the DSC analyses demonstrated that the enthalpy involved in the phase transition was approximately the same for all the polymers, including the polymer based on the standard diepoxide DGEBA. Since the analyses did not reveal any differences in performance between the diepoxides, no more DSC experiments were performed. It should be noted that the Tg of the epoxy resin increases linearly and reaches a peak at a one-to-one ratio of amino-hydrogen to epoxy groups. At higher molar ratios of TETA to epoxy monomer, the Tg decreases linearly again. 46 This has been explained as a plasticization effect caused by an excess of curing agent, i.e., TETA. 47 Figure 4 shows TGA thermograms of the epoxy resins investigated in this study. Thermal stability and degradation data of the epoxy resins (i.e. IDT, Ea, Tmax, and Rmax) are summarized in Table 1 . Initial decomposition temperature (IDT) indicates the apparent thermal stability of the epoxy resin, i.e., the failure temperatures of the resin in processing and molding, and is determined from the onset of weight loss of the sample in the TGA thermogram. The activation energy (Ea) for the decomposition of the cured epoxy resins was calculated from the TGA thermogram through the integral method based on the Horwitz-Metzger equation. 48, 49 The maximum weight loss rate (Rmax) and the temperature at maximum rate of weight loss (Tmax)
were taken from the peak values of the differential thermograms. Epoxy resins based on DGEBA and DGEBF were used as controls.
almost the same thermal stability profiles as the epoxy resins based on the control samples. This demonstrates that the reactivity with TETA was approximately the same for ERMs 1, 2, 5 and 6
as for DGEBA and DGEBF and also that the degree of cross-linking obtained with these six ERMs was almost the same. The IDT of the epoxy resins based on ERMs 3 and 4 was considerably lower than the IDT obtained for the other epoxy resins, indicating that these two compounds would be less suitable as commercial replacements for DGEBA and DGEBF. One possible reason for the lower decomposition temperature of the compound 3-and 4-based epoxy resins could be higher reactivity of these monomers against TETA, resulting in a lower degree of cross-linking. The activation energy (Ea) of the epoxy resins based on 5 and 6 was of the same magnitude as for resins based on DGEBA and DGEBF (Table 1) . Taken together, the TGA data indicate that from a polymerization point of view 5 and 6 are the preferred ERMs, both giving polymers with TETA with a thermal stability close to that obtained with the commercial diepoxides DGEBA and DGEBF.
There has been much unresolved discussion about the health effects of bisphenol A (BPA), which is used in the production of DGEBA. 50 The focus of our work was not to replace BPA but to reduce the skin sensitizing potency and the cause of epidemics in the factories where the unfortunately these measures only address the effects of the problem rather than the cause. Our approach recognizes that the cause of the problem is the inherent reactivity of epoxy groups, and suggests a solution based on reducing the skin sensitization potencies of the occupational allergens used. Use of the novel ERMs reported in this paper, particularly ERMs 5 and 6, has the potential to decrease the incidence of ACD due to ERS, decrease the healthcare costs involved with the diagnosis and treatment of such allergies, and increase the quality of life for persons handling ERS-containing thermosetting materials.
Conclusion
The aim of this research was to investigate structural modifications to existing ERMs, DGEBA and DGEBF, with a view to reducing their sensitizing potency. A series of six novel ERMs was synthesized and found to have reduced sensitizing potency in in vivo models. The reduction in skin sensitizing potency was demonstrated to be statistically significant for compound 5 compared to DGEBA. In a preliminary assessment of their technical polymerization properties, four of the six new monomers were found to be comparable to DGEBA and DGEBF. It is anticipated that these new ERMs, particularly compounds 5 and 6, will be useful as replacements for DGEBA and DGEBF in many occupational applications, reducing the risk of allergic contact dermatitis to those working with epoxy resin systems. Table S3 . Polymerization parameters and characteristics of different epoxy resins from DSC a Groups of mice were treated with the test substance in five different concentrations, on the dorsum of both ears for three consecutive days. Control animals received the vehicle alone. On day five, all mice were injected intravenously with PBS (250 µL) containing 20 µCi of [methyl-3 H]thymidine. After 5 h the mice were sacrificed, the draining lymph nodes were excised and pooled for each group, single cell suspensions of lymph-node cells were prepared, and the thymidine incorporation into DNA was measured by β-scintillation counting. The increase in thymidine incorporation relative to vehicle-treated controls was derived for each experimental group and recorded as stimulation index (SI). The EC3 values (the estimated concentration required to induce a SI of 3) were calculated using linear interpolation 
